Who owns ONKURE THERAPEUTICS INC-A?
- Ticker: OKUR
- CUSIP Number: 68277q105
Tip: Access positions for across all investors
Analyze quarterly positions in Onkure Therapeutics Inc-a with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Onkure Therapeutics Inc-a stock
Who bought or sold ONKURE THERAPEUTICS INC-A this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Acorn Capital Advisors | 2.8M | $8.2M | 0% | Dec 2025 |
|
| Citadel Advisors | 1.0M | $2.8M | -7% | Sep 2025 |
|
| ADAR1 Capital Management | 1.0M | $2.9M | 100% | Dec 2025 |
|
| Prosight Management | 817k | $2.4M | 205% | Dec 2025 |
|
| None | 781k | $2.3M | 100% | Dec 2025 |
|
| Rosalind Advisors | 731k | $2.1M | 100% | Dec 2025 |
|
| Vestal Point Capital | 635k | $1.8M | 0% | Dec 2025 |
|
| Vanguard Group | 627k | $1.8M | -8% | Dec 2025 |
|
| Highbridge Capital Management | 542k | $1.6M | -17% | Dec 2025 |
|
| StepStone | 492k | $1.4M | 0% | Dec 2025 |
|
| NEA Management Company | 479k | $1.4M | 0% | Dec 2025 |
|
| Cantor Fitzgerald, L. P. | 445k | $1.3M | -10% | Dec 2025 |
|
| Carlyle | 270k | $772k | 0% | Dec 2025 |
|
| Renaissance Technologies | 247k | $717k | 41% | Dec 2025 |
|
| Rangeley Capital | 145k | $421k | -7% | Dec 2025 |
|
| Aisling Capital Management | 89k | $257k | 0% | Dec 2025 |
|
| Geode Capital Management | 78k | $225k | -9% | Dec 2025 |
|
| Sphera Funds Management | 61k | $175k | 0% | Dec 2025 |
|
| BlackRock | 53k | $153k | -91% | Dec 2025 |
|
| GSA Capital Partners | 46k | $133k | -22% | Dec 2025 |
|
| Aldebaran Capital | 41k | $120k | -6% | Dec 2025 |
|
| Barclays | 27k | $79k | 4287% | Dec 2025 |
|
| Two Sigma Advisers | 27k | $73k | -1% | Sep 2025 |
|
| Two Sigma Investments | 25k | $70k | -2% | Sep 2025 |
|
| Northern Trust | 20k | $58k | -12% | Dec 2025 |
|
| Bridgeway Capital Management | 20k | $54k | -22% | Sep 2025 |
|
| Jane Street | 19k | $56k | 100% | Dec 2025 |
|
| XTX Topco | 18k | $52k | 100% | Dec 2025 |
|
| Wells Fargo & Company | 11k | $32k | 16% | Dec 2025 |
|
| UBS Group | 1.2k | $3.5k | 489% | Dec 2025 |
|
| Jpmorgan Chase & Co | 423.00 | $1.2k | 100% | Sep 2025 |
|
| Bnp Paribas Arbitrage, Snc | 281.00 | $815.012400 | -23% | Dec 2025 |
|
| Royal Bank of Canada | 190.00 | $1.0k | -23% | Sep 2025 |
|
| Trust Co Of Toledo Na | 136.00 | $394.005600 | 0% | Dec 2025 |
|
| Advisor Group Holdings | 109.00 | $316.001900 | 9% | Dec 2025 |
|
| Group One Trading | 56.00 | $162.002400 | 0% | Dec 2025 |
|
| FMR | 50.00 | $138.000000 | 100% | Sep 2025 |
|
| Northwestern Mutual Wealth Management Company | 2.00 | $6.000000 | 100% | Dec 2025 |
|
Who sold out of Onkure Therapeutics Inc-a?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Shay Capital | Sep 2025 | 918k | $2.5M |
| Tang Capital Management | Sep 2025 | 116k | $320k |
| China Universal Asset Management | Sep 2025 | 2.3k | $6.2k |
| Tower Research Capital | Sep 2025 | 1.9k | $5.3k |
| Mirae Asset Global Investments | Sep 2025 | 497.00 | $1.4k |
| Gf Fund Management | Sep 2025 | 271.00 | $745.006100 |
| MAI Wealth Advisors | Sep 2025 | 6.00 | $16.999800 |